Quarterly report pursuant to sections 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v2.4.0.8
Consolidated Balance Sheets (Unaudited) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Current assets:    
Cash $ 5,864,388 $ 2,354,169
Accounts receivable 330,000   
Marketable securities - available for sale securities 6,250 12,500
Prepaid expenses 321,025 40,333
Assets of discontinued operations - current portion    82,145
Total current assets 6,521,663 2,489,147
Other assets:    
Property and equipment, net 8,056   
Intangible assets, net 3,217,007 492,152
Goodwill 2,144,488   
Assets of discontinued operations - long term portion    1,035,570
Total other assets 5,369,551 1,527,722
Total Assets 11,891,214 4,016,869
Current liabilities:    
Accounts payable and accrued expenses 372,552 57,158
Liabilities of discontinued operations 30,664 30,664
Total liabilities 403,216 87,822
Stockholders' Equity:    
Preferred stock, $.0001 par value, 50,000,000 shares authorized: none issued and outstanding      
Common stock, ($.0001 par value; 200,000,000 shares authorized; 5,337,679 and 3,503,565 issued and outstanding at September 30, 2013 and December 534 352
Additional paid-in capital 20,917,699 10,976,325
Subscription receivable (25,000)   
Accumulated other comprehensive income - marketable securities available for sale (6,250)   
Deficits accumulated during the development stage (9,388,489) (7,037,134)
Total Marathon Patent Group, Inc. equity 11,498,494 3,939,543
Non-controlling interest in subsidiary (10,496) (10,496)
Total stockholders' equity 11,487,998 3,929,047
Total liabilities and stockholders' equity $ 11,891,214 $ 4,016,869